Craig Adam R
SEC insider (Form 3/4/5 filer). CIK 0001339498. Executive Chairman at X4 Pharmaceuticals, Inc (XFOR). 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 16, 2026. Located in BOSTON, MA.
Companies Craig Adam R has filed insider reports for
- X4 Pharmaceuticals, Inc (XFOR): Director, Officer, Executive Chairman
Craig Adam R
CIK: 0001339498
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
X4 Pharmaceuticals, Inc
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Oct 16, 2026XFOR
X4 Pharmaceuticals, Inc
PurchaseDirect4.6K shares at avg. $2.58$12K - Aug 12, 2026XFOR
X4 Pharmaceuticals, Inc
SaleDirect47.4K shares at avg. $4.44$211K - Oct 29, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirectStock Option (right to buy)
2.3M shares- - Oct 23, 2025XFOR
X4 Pharmaceuticals, Inc
PurchaseDirect86.2K shares at avg. $2.90$250K - Aug 14, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirect289.9K shares- - Aug 12, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirectStock Option (right to buy)
1.6M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 16, 2026 | XFOR X4 Pharmaceuticals, Inc | Purchase | 4,600 | $2.58 | $11,884 | Direct |
| Aug 12, 2026 | XFOR X4 Pharmaceuticals, Inc | Sale | 47,436 | $4.44 | $210,829 | Direct |
| Oct 29, 2025 | XFOR X4 Pharmaceuticals, Inc | Award Stock Option (right to buy) | 2,329,154 | - | - | Direct |
| Oct 23, 2025 | XFOR X4 Pharmaceuticals, Inc | Purchase | 86,206 | $2.90 | $249,997 | Direct |
| Aug 14, 2025 | XFOR X4 Pharmaceuticals, Inc | Award | 289,881 | - | - | Direct |
| Aug 12, 2025 | XFOR X4 Pharmaceuticals, Inc | Award Stock Option (right to buy) | 1,609,873 | - | - | Direct |
1-6 of 6 transactions